According to NewAmsterdam Pharma Company's latest financial reports the company's current revenue (TTM) is $14.09 M. In 2023 the company made a revenue of $14.09 M a decrease over the years 2022 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | $14.09 M | -87.19% |
2022 | $0.10 B | |
2021 | N/A | |
2020 | N/A |